---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-063946"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T15:52:09.776962+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q1 adjusted EPS $0.33; raises FY2025 EBITDA guidance to $220-240M

## Summary
- Net revenue $458M, down 7% YoY due to dispositions; same-unit revenue grew 6.2% on improved payor mix and volume.
- Adjusted EBITDA $49.2M (up 32% YoY); GAAP EPS $0.24 vs $0.05; Adjusted EPS $0.33 vs $0.20.
- Raised FY2025 Adjusted EBITDA guidance to $220-240M from $215-235M after strong Q1.
- Cash from ops used $116.1M for seasonal incentive comp; total debt $611M, no revolver draw.
- Same-unit volume: NICU days +2.0%, hospital-based +1.7%, office-based +2.6% YoY.

## SEC filing metadata
- accession: 0000950170-25-063946
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017025063946/0000950170-25-063946-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017025063946/md-20250506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-063946
- JSON: https://secwatch.observer/filing/0000950170-25-063946.json
- Plain text: https://secwatch.observer/filing/0000950170-25-063946.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.